Like other rich countries, Japan is signing multiple deals because
some of the vaccines could fail in clinical trials or require more
than one dose.
But Japan has something else riding on a successful mass rollout of
a vaccine: outgoing Prime Minister Shinzo Abe's aim to bring
thousands of athletes and fans to Tokyo for the Games, postponed
from this year due to the pandemic.
On the day he announced his resignation as premier, Abe sought to
reassure domestic and foreign audiences that the coronavirus was
under control. He pledged there would be enough vaccine for Japan by
the middle of 2021 and said the nation would relax its travel ban
from Sept. 1.
Chief Cabinet Secretary Yoshihide Suga earlier had said Japan was
working with Olympic organisers on how to go ahead with the Games,
tying the effort to the need to secure a vaccine.

The various companies "will probably be able to produce a vaccine
between the end of this year and next March", Suga told Reuters in
an interview this week. "There are a lot of considerations, but we
want to hold the Olympics at all costs."
Japan is on track to have 521 million doses of five different
vaccines in 2021, compared with a population of 126 million. Recent
deals include global arrangements with such drugmakers as Pfizer Inc
<PFE.N> and AstraZeneca PLC <AZN.L>, as well as local deals with the
likes of Shionogi & Co. <4507.T>. "You have to bet evenly to avoid
getting nothing," said Tomoya Saito, director at Japan's National
Institute of Public Health.
'HOPE FOR A MIRACLE'
Some critics contend that Japan's rush to secure supplies is driven
largely by a political desire to show the world it is fully
committed to the Games. "The plan is, hope for a miracle and then
capitalise on that miracle," said Michael Cucek, a political science
professor at Temple University Japan. "But the timeframe for that is
getting narrower and narrower." Health ministry and cabinet Office
officials did not respond to queries about whether Japan's drive to
secure coronavirus vaccines was connected to the Olympics.
[to top of second column] |

Abe pledged to increase testing capacity to 200,000 per day along with securing
vaccine supplies. He also said Japan's travel ban, one of the strictest in the
world, would ease on Sept. 1.
From that date, non-citizen residents of Japan and visa holders can leave and
reenter the country, with prior authorisation. They must also demonstrate a
negative coronavirus test result within 72 hours of returning to Japan, cabinet
officials said at a briefing on Friday.Japanese officials have discussed putting
on a "simplified" Games, originally expected to attract 600,000 visitors. But
the event would still involve some 11,000 athletes.
Holding the Olympics requires "mass quantities of an effective vaccine", said
Kenji Shibuya, director of the Institute of Population Health at King's College,
London. Staging an Olympics in a pandemic will be a huge logistical challenge,
as athletes will have to train and travel to events and many more thousands of
fans will have to be accommodated at a time when many countries may still be in
lockdown. Japan still has a travel ban in place covering more than 140
countries.
Even with a viable vaccine, the additional challenge of immunising athletes and
visitors before or after landing in Japan will be enormous.
A "very, very essential factor" will be when an effective vaccine will be ready
and how it will be distributed, Tokyo Governor Yuriko Koike told Reuters.

"We will do our best to prevent coronavirus infections here in Japan and also to
welcome the athletes from all over the world."
(Reporting by Rocky Swift; Editing by David Dolan, William Mallard and Nick
Macfie)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |